The number of FIIs with shareholding in the company rose to 984 from 897 at the end of the December 2013 quarter, shareholding data on exchanges showed. FIIs have increased their holding in the company by nearly 300 bps since the Infosys board appointed N R Narayana Murthy as executive chairman in June 2013. At the end of the June quarter, they’d held 39.55 per cent stake. On the other hand, the shareholding of India-based mutual funds and insurance companies has declined by about 200 bps during this period.
Analysts said the exits of nine top-level employees in the second half of 2013 could have a bearing on Infosys’ performance in the medium term.
The company itself indicated it could miss the top end of its 2013-14 revenue growth forecast of 12 per cent. The company has underperformed its larger peer, Tata Consultancy Services’ (TCS) financial performance consistently in the past. The Infosys stock trades at a steep discount (nearly 20 per cent, to 15.4 times the 2014-15 estimated earnings) to TCS (19 times FY15 estimated earnings).
In the March quarter, Infosys shares fell six per cent, underperforming the benchmark Nifty, which rose 5.7 per cent.
However, most analysts remain positive on the stock (given the low valuations). Of the 16 analysts polled by Bloomberg in April so far, 11 have a ‘buy’, four have a ‘hold’ and one brokerage has a ‘sell’ rating on the stock. Their average target price is Rs 3,801 a share, a 16.9 per cent upside from Wednesday’s closing price of Rs 3,253.
Shashi Bhusan, an analyst with Prabhudas Lilladher, remains confident of an improving demand environment and an increased focus by Infosys to win large deals. He expects this to start yielding results in FY15 and retains a ‘Buy’, with a target price of Rs 4,550.
Analysts at JP Morgan maintain an ‘Overweight’ rating on the stock, with a December 2014 price target of Rs 4,000.
“We continue to believe Mr Murthy’s diagnosis of Infosys’ problems is fairly accurate. Hopefully, he can also administer the right medicine/solutions, which might just take longer to heal than we expected,” said an analyst in a report dated April 1.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)